Health Care & Life Sciences » Biotechnology | Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.7
Market Cap
$1.64 M
Shares Outstanding
26.18 M
Public Float
26.12 M

Profile

Address
25801 Industrial Boulevard
Hayward California 94545
United States
Employees -
Website http://www.anthera.com
Updated 07/08/2019
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F.

Financials

View All

Paul F. Truex
Executive Chairman
John Craig Thompson
President, CEO & Executive Director